-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RthvZmr3EFkpuKVApalq6PzhkKwSmP7QaY4ikoAo0rCUWJtizTTYrFI5iQT/St9/ 6lI+SFb8xl+Xv+uK4j2z8Q== 0000902664-07-000822.txt : 20070214 0000902664-07-000822.hdr.sgml : 20070214 20070214104901 ACCESSION NUMBER: 0000902664-07-000822 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070214 DATE AS OF CHANGE: 20070214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS CORP CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-57843 FILM NUMBER: 07614695 BUSINESS ADDRESS: STREET 1: 1110 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1110 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GLG Partners LP CENTRAL INDEX KEY: 0001289643 IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1 CURZON STREET CITY: LONDON STATE: X0 ZIP: W1J 5HB BUSINESS PHONE: 44 20 7016 7000 MAIL ADDRESS: STREET 1: 1 CURZON STREET CITY: LONDON STATE: X0 ZIP: W1J 5HB SC 13G/A 1 sc13ga.txt UNITED THERAPEUTICS CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ---------------------- SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* United Therapeutics Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 91307C102 (CUSIP Number) December 31, 2006 (Date of Event Which Requires Filing of this statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [X] Rule 13d-1(c) [ ] Rule 13d-1(d) - ---------------- *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 9 Pages CUSIP No. 91307C102 13G/A Page 2 of 9 Pages - --------------------------------------------------------------------------- (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) GLG Partners LP - --------------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [X] (b) [ ] - --------------------------------------------------------------------------- (3) SEC USE ONLY - --------------------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION United Kingdom - --------------------------------------------------------------------------- NUMBER OF (5) SOLE VOTING POWER 0 SHARES ------------------------------------------------------------ BENEFICIALLY (6) SHARED VOTING POWER 1,545,497 Shares OWNED BY ------------------------------------------------------------ EACH (7) SOLE DISPOSITIVE POWER 0 REPORTING ------------------------------------------------------------ PERSON WITH: (8) SHARED DISPOSITIVE POWER 1,545,497 Shares - --------------------------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,545,497 Shares - --------------------------------------------------------------------------- (10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - --------------------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.19% - --------------------------------------------------------------------------- (12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - --------------------------------------------------------------------------- CUSIP No. 91307C102 13G/A Page 3 of 9 Pages - --------------------------------------------------------------------------- (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) GLG Partners Limited - --------------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [X] (b) [ ] - --------------------------------------------------------------------------- (3) SEC USE ONLY - --------------------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION United Kingdom - --------------------------------------------------------------------------- NUMBER OF (5) SOLE VOTING POWER 0 SHARES ------------------------------------------------------------ BENEFICIALLY (6) SHARED VOTING POWER 1,545,497 Shares OWNED BY ------------------------------------------------------------ EACH (7) SOLE DISPOSITIVE POWER 0 REPORTING ------------------------------------------------------------ PERSON WITH: (8) SHARED DISPOSITIVE POWER 1,545,497 Shares - --------------------------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,545,497 Shares - --------------------------------------------------------------------------- (10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - --------------------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.19% - --------------------------------------------------------------------------- (12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IA, HC - --------------------------------------------------------------------------- CUSIP No. 91307C102 13G/A Page 4 of 9 Pages - --------------------------------------------------------------------------- (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Noam Gottesman - --------------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [X] (b) [ ] - --------------------------------------------------------------------------- (3) SEC USE ONLY - --------------------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION United States - --------------------------------------------------------------------------- NUMBER OF (5) SOLE VOTING POWER 0 SHARES ------------------------------------------------------------ BENEFICIALLY (6) SHARED VOTING POWER 1,545,497 Shares OWNED BY ------------------------------------------------------------ EACH (7) SOLE DISPOSITIVE POWER 0 REPORTING ------------------------------------------------------------ PERSON WITH: (8) SHARED DISPOSITIVE POWER 1,545,497 Shares - --------------------------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,545,497 Shares - ----------------------------------------------------------------------- (10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - --------------------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.19% - --------------------------------------------------------------------------- (12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN, HC - --------------------------------------------------------------------------- CUSIP No. 91307C102 13G/A Page 5 of 9 Pages - --------------------------------------------------------------------------- (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Pierre Lagrange - --------------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [X] (b) [ ] - --------------------------------------------------------------------------- (3) SEC USE ONLY - --------------------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION Belgium - --------------------------------------------------------------------------- NUMBER OF (5) SOLE VOTING POWER 0 SHARES ------------------------------------------------------------ BENEFICIALLY (6) SHARED VOTING POWER 1,545,497 Shares OWNED BY ------------------------------------------------------------ EACH (7) SOLE DISPOSITIVE POWER 0 REPORTING ------------------------------------------------------------ PERSON WITH: (8) SHARED DISPOSITIVE POWER 1,545,497 Shares - --------------------------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,545,497 Shares - --------------------------------------------------------------------------- (10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - --------------------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.19% - --------------------------------------------------------------------------- (12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN, HC - --------------------------------------------------------------------------- CUSIP No. 91307C102 13G/A Page 6 of 9 Pages - --------------------------------------------------------------------------- (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Emmanuel Roman - --------------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [X] (b) [ ] - --------------------------------------------------------------------------- (3) SEC USE ONLY - --------------------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION France - --------------------------------------------------------------------------- NUMBER OF (5) SOLE VOTING POWER 0 SHARES ------------------------------------------------------------ BENEFICIALLY (6) SHARED VOTING POWER 1,545,497 Shares OWNED BY ------------------------------------------------------------ EACH (7) SOLE DISPOSITIVE POWER 0 REPORTING ------------------------------------------------------------ PERSON WITH: (8) SHARED DISPOSITIVE POWER 1,545,497 Shares - --------------------------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,545,497 Shares - --------------------------------------------------------------------------- (10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - --------------------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.19% - --------------------------------------------------------------------------- (12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN, HC - --------------------------------------------------------------------------- CUSIP No. 91307C102 13G/A Page 7 of 9 Pages This Amendment No. 1 (this "Amendment") amends the statement on Schedule 13G filed on December 15, 2006 (as amended, the "Schedule 13G") with respect to shares of Common Stock, par value $0.01 per share ("Common Stock") of United Therapeutics Corporation, a Delaware corporation (the "Company"). In addition to the 1,545,497 Shares owned by the Reporting Persons (as defined below), the Reporting Persons beneficially own $8,000,000 principal amount of 0.50% Convertible Senior Notes Due October 15, 2011 convertible into 106,346 Shares. However, pursuant to the terms of the relevant indenture, the Reporting Persons cannot convert any of these convertible senior notes until such time as the market price of the Common Stock reach a certain price threshold, which, as of the date hereof, has not been reached. Capitalized terms used herein and not otherwise defined in this Amendment have the meanings set forth in the Schedule 13G. This Amendment amends and restates Items 2(a), 2(b), 2(c), 4, 5 and 8 in their entirety as set forth below. Item 2(a). Name of Person Filing This statement is filed by the entities and persons listed below, who are collectively referred to herein as "Reporting Persons," with respect to the shares of Common Stock of the Company, $0.01 par value per share (the "Shares"): INVESTMENT MANAGER (i) GLG Partners LP (the "Investment Manager"), with respect to the Shares held by certain funds to which the Investment Manager serves as investment manager (collectively, the "GLG Funds"). GENERAL PARTNER (ii) GLG Partners Limited (the "General Partner"), which serves as the general partner of the Investment Manager, with respect to the Shares held by each of the GLG Funds. REPORTING INDIVIDUALS (iii) Mr. Noam Gottesman ("Mr. Gottesman"), with respect to the Shares held by each of the GLG Funds. (iv) Mr. Pierre Lagrange ("Mr. Lagrange"), with respect to the Shares held by each of the GLG Funds. (v) Mr. Emmanuel Roman ("Mr. Roman"), with respect to the Shares held by each of the GLG Funds. Mr. Gottesman, Mr. Lagrange and Mr. Roman are collectively referred to as the "Reporting Individuals." The Investment Manager serves as the investment manager to each of the GLG Funds. The General Partner serves as the general partner to the Investment Manager. Each of the Reporting Individuals is a Managing Director of the General Partner. Item 2(b). Address of Principal Business Office or, if none, Residence The address of the principal business office of each of the Reporting Persons is: CUSIP No. 91307C102 13G/A Page 8 of 9 Pages c/o GLG Partners LP 1 Curzon Street London W1J 5HB United Kingdom Item 2(c). Citizenship Citizenship is set forth in Row 4 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. The information required by Items 4(a) - (c) is set forth in Rows 5 - 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. The Company's most recent Registration Statement on Form S-3ASR that was filed on December 22, 2006, indicates there were 21,503,408 Shares outstanding as of December 19, 2006. In calculating the percentage of Shares held by the Reporting Persons, we assumed the conversion of the reported convertible senior notes. The Investment Manager, which serves as the investment manager to each of the GLG Funds, may be deemed to be the beneficial owner of all Shares owned by the GLG Funds. The General Partner, as general partner to the Investment Manager, may be deemed to be the beneficial owner of all Shares owned by the GLG Funds. Each of the Reporting Individuals, as a Managing Director of the General Partner with the power to exercise investment discretion, may be deemed to be the beneficial owner of all Shares owned by the GLG Funds. Each of the Investment Manager, the General Partner, and the Reporting Individuals hereby disclaims any beneficial ownership of any such Shares, except for their pecuniary interest therein. Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [ ] Item 8. Identification and Classification of Members of the Group See Exhibit I of Schedule 13G filed on December 15, 2006 with respect to the Shares. CUSIP No. 91307C102 13G/A Page 9 of 9 Pages SIGNATURES After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct. Dated: February 14, 2007 GLG PARTNERS LIMITED GLG PARTNERS LP By: GLG Partners Limited, as its General Partner /s/ Emmanuel Roman - ---------------------------- Name: Emmanuel Roman Title: Managing Director /s/ Emmanuel Roman ------------------------------ Name: Emmanuel Roman /s/ Victoria Parry Title: Managing Director - ---------------------------- Name: Victoria Parry Title: Senior Legal Counsel /s/ Victoria Parry ------------------------------ Name: Victoria Parry Title: Senior Legal Counsel /s/ Emmanuel Roman - -------------------------------- EMMANUEL ROMAN, individually and on behalf of Noam Gottesman and Pierre Lagrange The Powers of Attorney executed by Noam Gottesman and Pierre Lagrange, authorizing Emmanuel Roman to sign and file this Schedule 13G/A on each person's behalf, which were filed with the Schedule 13G filed with the Securities and Exchange Commission on December 15, 2006 by such Reporting Persons with respect to the common stock of Movado Group, Inc., are hereby incorporated by reference. -----END PRIVACY-ENHANCED MESSAGE-----